Stifel Raises SpyGlass Pharma Price Target to $44
Bullish analyst update with implied upside, tempered by the absence of the prior target and the fact that targets are opinions.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst update with implied upside, tempered by the absence of the prior target and the fact that targets are opinions.
What happened, with direct paths to the underlying reporting
Stifel raised its target on SpyGlass Pharma to $44 from an unspecified prior level; the posted price was $33.44.
Target: $44
Posted price: $33.44
Analyst firm: Stifel Nicolaus
Analyst: Tom Stephan
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.